1. Home
  2. NVAX vs APLD Comparison

NVAX vs APLD Comparison

Compare NVAX & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • APLD
  • Stock Information
  • Founded
  • NVAX 1987
  • APLD 2001
  • Country
  • NVAX United States
  • APLD United States
  • Employees
  • NVAX N/A
  • APLD N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • APLD Investment Bankers/Brokers/Service
  • Sector
  • NVAX Health Care
  • APLD Finance
  • Exchange
  • NVAX Nasdaq
  • APLD Nasdaq
  • Market Cap
  • NVAX 2.0B
  • APLD 1.6B
  • IPO Year
  • NVAX 1995
  • APLD N/A
  • Fundamental
  • Price
  • NVAX $8.57
  • APLD $7.80
  • Analyst Decision
  • NVAX Buy
  • APLD Strong Buy
  • Analyst Count
  • NVAX 6
  • APLD 7
  • Target Price
  • NVAX $17.83
  • APLD $11.29
  • AVG Volume (30 Days)
  • NVAX 3.3M
  • APLD 17.1M
  • Earning Date
  • NVAX 02-26-2025
  • APLD 01-14-2025
  • Dividend Yield
  • NVAX N/A
  • APLD N/A
  • EPS Growth
  • NVAX N/A
  • APLD N/A
  • EPS
  • NVAX N/A
  • APLD N/A
  • Revenue
  • NVAX $885,193,000.00
  • APLD $189,956,000.00
  • Revenue This Year
  • NVAX N/A
  • APLD $64.99
  • Revenue Next Year
  • NVAX N/A
  • APLD $55.02
  • P/E Ratio
  • NVAX N/A
  • APLD N/A
  • Revenue Growth
  • NVAX N/A
  • APLD 124.03
  • 52 Week Low
  • NVAX $3.53
  • APLD $2.36
  • 52 Week High
  • NVAX $23.86
  • APLD $11.25
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 48.28
  • APLD 43.30
  • Support Level
  • NVAX $7.62
  • APLD $7.41
  • Resistance Level
  • NVAX $8.67
  • APLD $9.35
  • Average True Range (ATR)
  • NVAX 0.46
  • APLD 0.85
  • MACD
  • NVAX -0.03
  • APLD -0.19
  • Stochastic Oscillator
  • NVAX 44.60
  • APLD 13.64

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About APLD Applied Digital Corporation

Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments; Data Center Hosting Business, Cloud Services Business, and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business which operates data centers to provide energized space to crypto mining customers.

Share on Social Networks: